Patents by Inventor Michael SCHOTSAERT

Michael SCHOTSAERT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12552788
    Abstract: Provided herein are lipidated imidazoquinoline compounds and compositions comprising such compounds. The lipidated imidazoquinoline compounds may be used as an adjuvant to enhance to immune response elicited by an antigen of interest. Accordingly, also provided herein are methods for enhancing the immune response of an antigen of interest in a subject, comprising administering to the subject an antigen of interest with a lipidated imidazoquinoline compound described herein in an immunogenic composition, or administering to the subject a composition comprising a lipidated imidazoquinoline compound described herein in combination with (e.g., prior to, concurrently, or subsequently) the administration of an immunogenic composition comprising an antigen of interest to the subject.
    Type: Grant
    Filed: October 7, 2021
    Date of Patent: February 17, 2026
    Assignees: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, UNIVERSITEIT GENT
    Inventors: Adolfo Garcia-Sastre, Michael Schotsaert, Angela Choi, Bruno De Geest, Jana De Vrieze
  • Publication number: 20240252620
    Abstract: The disclosure is directed to compositions and methods for inducing an immune response against a coronavirus, which involve a coronavirus vaccine and an adjuvant composition. The adjuvant composition comprises a nanoemulsion, an agonist of retinoic acid-inducible gene I (RIG-I), and/or an agonist of a toll-like receptor.
    Type: Application
    Filed: May 26, 2022
    Publication date: August 1, 2024
    Inventors: Pamela Wong, James Baker, Sonia Jangra, Adolfo Garcia-Sastre, Michael Schotsaert
  • Publication number: 20230373997
    Abstract: Provided herein are lipidated imidazoquinoline compounds and compositions comprising such compounds. The lipidated imidazoquinoline compounds may be used as an adjuvant to enhance to immune response elicited by an antigen of interest. Accordingly, N also provided herein are methods for enhancing the immune response of an antigen of interest in a subject, comprising administering h to the subject an antigen of interest with a lipidated imidazoquinoline compound described herein in an immunogenic composition, or administering to the subject a composition comprising a lipidated imidazoquinoline compound described herein in combination with N (e.g., prior to, concurrently, or subsequently) the administration of an immunogenic composition comprising an antigen of interest to the subject.
    Type: Application
    Filed: October 7, 2021
    Publication date: November 23, 2023
    Applicants: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, UNIVERSITEIT GENT
    Inventors: Adolfo GARCIA-SASTRE, Michael SCHOTSAERT, Angela CHOI, Bruno DE GEEST, Jana DE VRIEZE